These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25858663)

  • 21. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients.
    Monto A; Kakar S; Dove LM; Bostrom A; Miller EL; Wright TL
    Am J Gastroenterol; 2006 Jul; 101(7):1509-15. PubMed ID: 16863554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
    Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
    HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection.
    Wheeler AL; Scherzer R; Lee D; Delaney JA; Bacchetti P; Shlipak MG; Sidney S; Grunfeld C; Tien PC;
    AIDS; 2014 Jan; 28(1):49-58. PubMed ID: 24136113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage.
    Deenen MJ; de Kanter CT; Dofferhoff AS; Grintjes-Huisman KJ; van der Ven AJ; Fleuren HW; Gisolf EH; Koopmans PP; Drenth JP; Burger DM
    Ther Drug Monit; 2015 Dec; 37(6):751-5. PubMed ID: 26102531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons.
    Chew KW; Liu CY; Ambale-Venkatesh B; Liao D; Horwich TB; Lima JAC; Bluemke DA; Paul Finn J; Butt AA; Currier JS
    J Int Med Res; 2017 Dec; 45(6):1693-1707. PubMed ID: 28606026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.
    Bedimo R; Maalouf NM; Lo Re V
    Curr Opin HIV AIDS; 2016 May; 11(3):285-93. PubMed ID: 26890206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
    Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
    AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
    Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
    HIV Med; 2018 Oct; 19(9):597-604. PubMed ID: 29932291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
    Thein H; Maruff P; Krahn M; Kaldor J; Koorey Dj; Brew B; Dore G
    HIV Med; 2007 Apr; 8(3):192-202. PubMed ID: 17461864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    Montes ML; Olveira A; Ahumada A; Aldámiz T; García-Samaniego J; Clemente A; Berenguer J; González-García J; Martín-Carbonero L;
    AIDS; 2017 Jun; 31(9):1253-1260. PubMed ID: 28358742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
    Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
    Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects.
    Butt AA; Justice AC; Skanderson M; Good C; Kwoh CK
    Aliment Pharmacol Ther; 2006 Aug; 24(4):585-91. PubMed ID: 16907891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
    Bräu N
    Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.
    Durier N; Yunihastuti E; Ruxrungtham K; Kinh NV; Kamarulzaman A; Boettiger D; Widhani A; Avihingsanon A; Huy BV; Syed Omar SF; Sanityoso A; Chittmittrapap S; Dung NT; Pillai V; Suwan-Ampai T; Law M; Sohn AH; Matthews G
    J Viral Hepat; 2017 Mar; 24(3):187-196. PubMed ID: 27917597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study.
    Leone S; Lorenzini P; Cozzi-Lepri A; Orofino G; Bernacchia D; Castagna A; Menozzi M; Guaraldi G; Madeddu G; Di Biagio A; Puoti M; Gori A; d'Arminio Monforte A;
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1857-1865. PubMed ID: 31230205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.